Amanote Research
Register
Sign In
Digital Transcript Profile Analysis With aRNA-LongSAGE Validates FERMT1 as a Potential Novel Prognostic Marker for Colon Cancer
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-10-2552
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 10, 2011
Authors
J. Fan
D. Yan
M. Teng
H. Tang
C. Zhou
X. Wang
D. Li
G. Qiu
Z. Peng
Publisher
American Association for Cancer Research (AACR)
Related search
L1TD1 - A Prognostic Marker for Colon Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer
Clinical and Investigative Medicine
Medicine
Liver Receptor Homologue 1, a Novel Prognostic Marker in Colon Cancer Patients
Oncology Letters
Cancer Research
Oncology
PD23-04 THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GROα) AS a NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER
Journal of Urology
Urology
A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer
Clinical Cancer Research
Cancer Research
Oncology
Colon Cancer-Specific Antigen-2 May Be Used as a Detecting and Prognostic Marker in Colorectal Cancer: A Preliminary Observation
PLoS ONE
Multidisciplinary
MT1G Hypermethylation: A Potential Prognostic Marker for Hepatoblastoma
Pediatric Research
Child Health
Pediatrics
Perinatology
Realizing the Translational Potential of Telomere Length Variation as a Tissue-Based Prognostic Marker for Prostate Cancer